Marco Dotto

Marco Dotto is a prominent figure in the venture capital and biotechnology sectors, currently serving as a Limited Partner at Unruly Capital and Moonstone Venture Capital, while also holding a similar position at Eden Venture. As the Co-founder and CEO of Biodiversa s.r.l., Dotto leads a company specializing in Next Generation Sequencing services and bioinformatics for researchers and clinicians. Dotto is also an Angel Investor in various innovative healthcare startups, including Rubedo Life Sciences, focused on therapies targeting age-related diseases, and Nurture Genomics, which enhances pediatric care through genomic insights. Additional investments include SiZable Energy, developing cost-effective energy storage solutions, and active participation with Italian Angels for Growth. Dotto's educational background encompasses advanced degrees in Biotechnology and Management from institutions like UC San Diego and Università degli Studi di Padova.